Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LPAR2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | ZBTB18 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | NUMA1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | FBLL1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | HMGB1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | ZBTB39 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | CEBPG | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |